“Toll” Extending Its Gate from Drosophila Development to T Cell Response: Implication in Innate Immunity, Adaptive Immunity and Immunotherapy

2011 ◽  
pp. 1 ◽  
Author(s):  
Subhasis Chattopadhyay ◽  
Sanjima Pal ◽  
Pratheek BM ◽  
Vikram S. Meena ◽  
Sujay Singh ◽  
...  
2021 ◽  
Vol 10 (21) ◽  
pp. 4833
Author(s):  
Dorota Kamińska ◽  
Hanna Augustyniak-Bartosik ◽  
Katarzyna Kościelska-Kasprzak ◽  
Marcelina Żabińska ◽  
Dorota Bartoszek ◽  
...  

Background. It is still unclear whether COVID-19 convalescent kidney transplant recipients (KTR) and hemodialysis (HD) patients can develop anti-SARS-CoV-2 adaptive immunity. The aim was to characterize and compare the immune response to the virus in HD patients and KTR. Methods. The study included 26 HD patients and 54 KTR—both convalescent (14 HD, 25 KTR) and unexposed. The immune response was assessed by determining the anti-SARS-CoV-2 antibodies in serum and specific T cell response via the interferon-gamma release assay (IGRA). Moreover, blood-morphology-derived parameters, immune cell phenotypes, and acute phase reactants were evaluated. Results. KRT and HD convalescents presented similar serum levels of anti-SARS-CoV-2 IgG and IgA. A negative correlation occurred between IgG and time after the infection was observed. There was a strong relationship between the prevalence of anti-SARS-CoV-2 cellular and humoral responses in both groups. Convalescent IGRA response was significantly higher in HD patients compared to KTR. Conclusions. HD patients and KTR develop humoral and cellular responses after COVID-19. The antibodies levels are similar in both groups of patients. SARS-CoV-2-reactive T cell response is stronger in HD patients compared to KTR. The SARS-CoV-2-specific IgG level decreases with time while IgA and a cellular response are maintained. IGRA proved to be a valuable test for the assessment of specific cellular immunity in immunocompromised HD patients and KTR.


2011 ◽  
Vol 79 (5) ◽  
pp. 2021-2030 ◽  
Author(s):  
Stephanie P. Jehl ◽  
Amy M. Doling ◽  
Kara S. Giddings ◽  
Armelle Phalipon ◽  
Philippe J. Sansonetti ◽  
...  

ABSTRACTCD8+T lymphocytes often play a primary role in adaptive immunity to cytosolic microbial pathogens. Surprisingly, CD8+T cells are not required for protective immunity to the enteric pathogenShigella flexneri, despite the ability ofShigellato actively secrete proteins into the host cytoplasm, a location from which antigenic peptides are processed for presentation to CD8+T cells. To determine why CD8+T cells fail to play a role in adaptive immunity toS. flexneri, we investigated whether antigen-specific CD8+T cells are primed during infection but are unable to confer protection or, alternatively, whether T cells fail to be primed. To test whetherShigellais capable of stimulating an antigen-specific CD8+T-cell response, we created anS. flexneristrain that constitutively secretes a viral CD8+T-cell epitope via theShigellatype III secretion system and characterized the CD8+T-cell response to this strain both in mice and in cultured cells. Surprisingly, no T cells specific for the viral epitope were stimulated in mice infected with this strain, and cells infected with the recombinant strain were not targeted by epitope-specific T cells. Additionally, we found that the usually robust T-cell response to antigens artificially introduced into the cytoplasm of cultured cells was significantly reduced when the antigen-presenting cell was infected withShigella. Collectively, these results suggest that antigen-specific CD8+T cells are not primed duringS. flexneriinfection and, as a result, afford little protection to the host during primary or subsequent infection.


Sign in / Sign up

Export Citation Format

Share Document